BioAge Labs, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Emeryville, CA
BIOA chart
What traders are saying about $BIOA
Latest postsBioAge Labs, Inc. news
- Rethinking longevity beyond a longer lifespan
Mass General Brigham ·
- BioAge Labs, Inc. Estimates – NASDAQ:BIOA
TradingView ·
- Here's Why We're Not Too Worried About BioAge Labs' (NASDAQ:BIOA) Cash Burn Situation
Simply Wall Street ·
- BioAge Labs (NasdaqGS:BIOA) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
Yahoo Finance ·
- BioAge Labs' Lead Drug Faces Uncertain Path as Data Looms, UBS Says
Yahoo Finance ·
- BioAge Labs to Present at Upcoming Investor Conferences
Yahoo Finance ·
- BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema
Yahoo Finance ·
- Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
Yahoo Finance ·
- BioAge Labs, Inc. (BIOA) Reports Q2 Loss, Beats Revenue Estimates
Yahoo Finance ·
- BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
Yahoo Finance ·
- BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection?
stocktwits.com ·
BioAge Labs, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $9.0M | $0 | – |
| Net income | -$80.6M | -$71.1M | -$63.9M |
| Diluted EPS | $-2.24 | $-6.63 | $-38.17 |
| Total assets (year end) | $294.9M | $358.2M | $25.9M |
| Cash and equivalents (year end) | $188.9M | $354.3M | $21.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BioAge Labs, Inc.
- Ticker
- BIOA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Emeryville, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1709941
Frequently asked questions
What exchange is BioAge Labs, Inc. listed on?
BioAge Labs, Inc. trades on the Nasdaq under the ticker symbol BIOA.
What industry is BioAge Labs, Inc. in?
BioAge Labs, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is BioAge Labs, Inc. headquartered?
BioAge Labs, Inc.'s business address on file with the SEC is in Emeryville, CA.
When does BioAge Labs, Inc.'s fiscal year end?
BioAge Labs, Inc.'s fiscal year ends on December 31.
How much revenue did BioAge Labs, Inc. report?
BioAge Labs, Inc. reported $9.0M in revenue for calendar year 2025, according to its SEC filings.